Cargando…

Clinical prodromes of neurodegeneration in Anderson-Fabry disease

OBJECTIVE: To estimate the prevalence of prodromal clinical features of neurodegeneration in patients with Anderson-Fabry disease (AFD) in comparison to age-matched controls. METHODS: This is a single-center, prospective, cross-sectional study in 167 participants (60 heterozygous females and 50 hemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Löhle, Matthias, Hughes, Derralynn, Milligan, Alan, Richfield, Linda, Reichmann, Heinz, Mehta, Atul, Schapira, Anthony H.V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390387/ https://www.ncbi.nlm.nih.gov/pubmed/25762709 http://dx.doi.org/10.1212/WNL.0000000000001450

Ejemplares similares

Evolution and clustering of prodromal parkinsonian features in GBA1 carriers
por: Mullin, Stephen, et al.
Publicado: (2019)

Fabry disease and incidence of cancer
por: Bird, Sarah, et al.
Publicado: (2017)

Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

The distribution of hypertrophy in anderson fabry disease
por: Sado, Daniel M, et al.
Publicado: (2011)

Anderson-Fabry disease in heart failure
por: Akhtar, M. M., et al.
Publicado: (2018)

Retinal thinning in Gaucher disease patients and carriers: Results of a pilot study()()
por: McNeill, Alisdair, et al.
Publicado: (2013)

Corrigendum to “Retinal thinning in Gaucher disease patients and carriers: Results of a pilot study” [Mol. Genet. Metab. 109 (2013) 221–223]
por: McNeill, Alisdair, et al.
Publicado: (2014)

Role of cardiac imaging in Anderson-Fabry cardiomyopathy
por: Serra, Walter, et al.
Publicado: (2019)

Pathologic substrate of gastropathy in Anderson-Fabry disease
por: Di Toro, Alessandro, et al.
Publicado: (2020)

Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
por: Beck, Michael, et al.
Publicado: (2015)

Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease
por: Sado, Daniel, et al.
Publicado: (2013)

A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers
por: McNeill, Alisdair, et al.
Publicado: (2012)

Agalsidase alfa (Replagal(™)) in the treatment of Anderson-Fabry disease
por: Pastores, Gregory M
Publicado: (2007)

Time of Anderson-Fabry Disease Detection and Cardiovascular Presentation
por: Selthofer-Relatic, K.
Publicado: (2018)

CMR demonstration of multiple morphological phenotypes in Anderson-Fabry disease
por: Deva, Djeven P, et al.
Publicado: (2015)

Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review
por: Caputo, Fabio, et al.
Publicado: (2021)

Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future
por: Esposito, Roberta, et al.
Publicado: (2021)

Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
por: Stamerra, Cosimo A., et al.
Publicado: (2021)

Advanced CMR Techniques in Anderson-Fabry Disease: State of the Art
por: Ponsiglione, Andrea, et al.
Publicado: (2023)

Controversies in Neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease
por: Löhle, Matthias, et al.
Publicado: (2011)

Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation
por: Yamamoto, Saori, et al.
Publicado: (2018)

Sex Differences in Anderson–Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women
por: Faro, Denise Cristiana, et al.
Publicado: (2023)

Angiokeratoma Corporis Diffusum: An Uncommon Case with Suspected Anderson Fabry Disease
por: Vadher, Priyanka, et al.
Publicado: (2020)

Anderson-fabry disease: role of traditional and new cardiac MRI techniques
por: Caredda, Gloria, et al.
Publicado: (2021)

Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study
por: Arends, Maarten, et al.
Publicado: (2017)

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
por: Duro, Giovanni, et al.
Publicado: (2018)

Anderson-Fabry’s Disease: A Rare but Treatable Case of Fever of Unknown Origin
por: Graziani, Francesca, et al.
Publicado: (2017)

Biomarkers and Imaging Findings of Anderson–Fabry Disease—What We Know Now
por: Beirão, Idalina, et al.
Publicado: (2017)

Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease
por: Graziani, Francesca, et al.
Publicado: (2020)

Does left ventricular function predict cardiac outcome in Anderson–Fabry disease?
por: Spinelli, Letizia, et al.
Publicado: (2020)

Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy
por: Graziani, Francesca, et al.
Publicado: (2020)

Radiofrequency ablation of ventricular tachycardia in Anderson–Fabry disease: a case series
por: Mills, Mark T, et al.
Publicado: (2021)

Anderson–Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?
por: Zedde, Marialuisa, et al.
Publicado: (2022)

Left atrial strain correlates with severity of cardiac involvement in Anderson-Fabry disease
por: Halfmann, Moritz C., et al.
Publicado: (2022)

Transcatheter Tricuspid Valve Replacement for Anderson Fabry Disease With Severe Tricuspid Regurgitation
por: Zhou, Guang-Wei, et al.
Publicado: (2022)

Migalastat HCl Reduces Globotriaosylsphingosine (Lyso-Gb(3)) in Fabry Transgenic Mice and in the Plasma of Fabry Patients
por: Young-Gqamana, Brandy, et al.
Publicado: (2013)

Reduced coronary flow reserve in Anderson-Fabry disease measured by transthoracic Doppler echocardiography
por: Dimitrow, Paweł Petkow, et al.
Publicado: (2005)

Evaluating enzyme replacement therapies for Anderson-Fabry disease: commentary on a recent report
por: Giugliani, Roberto, et al.
Publicado: (2018)

Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies
por: Averbuch, Tauben, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nmm2fj08sln2osmav94kilu3ji